MGI
TEVA icon

Miller Global Investments’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Miller Global Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Sell
4,469
-412
-8% -$13.7K 0.13% 154
2026
Q1 		$147K Sell
4,881
-89
-2% -$2.86K 0.13% 144
2025
Q4 		$155K Buy
+4,970
New +$122K 0.14% 140

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Miller Global Investments's TEVA Position: Q2 2026 in Review

Miller Global Investments reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 8.4% in Q2 2026, selling an estimated $13.7K and leaving 4,469 shares worth $151K. The position accounts for 0.13% of the portfolio, ranked #154.

Miller Global Investments first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $155K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Miller Global Investments held 4,469 shares of Teva Pharmaceutical Industries Limited worth $151K as of Q2 2026.
  • Miller Global Investments sold 412 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $13.7K.
  • Teva Pharmaceutical Industries Limited made up 0.13% of Miller Global Investments's portfolio in Q2 2026, its #154 holding.
  • Miller Global Investments first reported a position in Teva Pharmaceutical Industries Limited in Q4 2025 and has held it in 3 quarters since.
  • Miller Global Investments's Teva Pharmaceutical Industries Limited position peaked at $155K in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.